You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
I came across several posts that the MACS is not fine-tuned for Viral ChipSeq (eg SARS-CoV2) (See Post1, Post2. What parameters do you think needs to be adjusted to get reliable peaks?
The text was updated successfully, but these errors were encountered:
@Rohit-Satyam Couple of suggestions for small genome peak calling: 1. usually you need to downsample your data. MACS uses the p-values to measure significancy and a p-value is too sensitive when the sample size is overly large. You may get a significant p-value even if the fold change is small. A 50-100 fold genome coverage may already be good enough. ( fold coverage ~= read_lengthnumber_of_reads/genome_size, or number_of_reads ~= fold_coveragegenome_size/read_length ). 2. Assign a reasonable 'effective genome size' for callpeak -g option, if you know the genome size of the virus. 3. As the Post2 mentioned, try to use the fine-tuning steps described in this document: https://macs3-project.github.io/MACS/docs/Advanced_Step-by-step_Peak_Calling.html since it's more flexible.
I came across several posts that the MACS is not fine-tuned for Viral ChipSeq (eg SARS-CoV2) (See Post1, Post2. What parameters do you think needs to be adjusted to get reliable peaks?
The text was updated successfully, but these errors were encountered: